Dustin Deming (@docdustyd) 's Twitter Profile
Dustin Deming

@docdustyd

ID: 3300606370

calendar_today27-05-2015 16:08:00

270 Tweet

477 Followers

74 Following

Healio Gastroenterology (@healiogastro) 's Twitter Profile Photo

When Dustin Deming was diagnosed with #rectalcancer, it changed the way he practiced medicine 🥼 and cared for patients. “To be honest, I did not get what it meant to hear the word #cancer,” he said. Learn more about his journey at the 🔗 below: bit.ly/3Kyov4s

The V Foundation for Cancer Research (@thevfoundation) 's Twitter Profile Photo

Our researchers always amaze us! We're inspired by Dr. Deming's "Don't Ever Give Up!" spirit and commitment to game-changing research as one of our top notch grantees. Dustin Deming is creating a better tomorrow!

ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

Many thanks to the esteemed presenters and panelists who participated in the Robert L. Comis, MD #TranslationalScience Symposium: Kim Reiss Binder (Kim Reiss), Dr. Adalsteinsson, Harpreet Singh, MD, Dustin Deming, Mark, Angie DeMichele, MD, MSCE, FASCO, & Drs. Gade, Fowler, & Mahmood! #TherapyOptimization

Many thanks to the esteemed presenters and panelists who participated in the Robert L. Comis, MD #TranslationalScience Symposium: <a href="/KReissMD/">Kim Reiss Binder (Kim Reiss)</a>, Dr. Adalsteinsson, <a href="/harpreet_md/">Harpreet Singh, MD</a>, <a href="/DocDustyD/">Dustin Deming</a>, <a href="/md_stewart/">Mark</a>, <a href="/AngieDemichele/">Angie DeMichele, MD, MSCE, FASCO</a>, &amp; Drs. Gade, Fowler, &amp; Mahmood! #TherapyOptimization
Deb Gugel (@debgugel) 's Twitter Profile Photo

We are looking for a GI medical oncologist to join University of Wisconsin Department of Medicine, UW Hematology-Oncology and Palliative Care & UW Health | Carbone Cancer Center! Work with our supportive team as we continue to grow and thrive in exceptional clinical care and innovative research. Apply now: jobs.wisc.edu/jobs/gi-medica…

We are looking for a GI medical oncologist to join <a href="/uw_medicine/">University of Wisconsin Department of Medicine</a>, <a href="/uw_hemeoncpc/">UW Hematology-Oncology and Palliative Care</a> &amp; <a href="/UWCarbone/">UW Health | Carbone Cancer Center</a>! Work with our supportive team as we continue to grow and thrive in exceptional clinical care and innovative research. Apply now: jobs.wisc.edu/jobs/gi-medica…
Kristen Spencer (@kspencer725) 's Twitter Profile Photo

Took a stroll down memory lane and noted this all began in 2020! This has been a labor of love a long time in the making, and with the help of many of you it is finally a reality. How fitting it activated at #GI24. I’m coming for you KRAS! Perlmutter Cancer Center at NYU Langone Health Dustin Deming ECOG-ACRIN Cancer Research Group

Fight Colorectal Cancer (@fightcrc) 's Twitter Profile Photo

“I start every new visit by telling the patient who I am, what I’ve been through, and the fact that I’ve been in their shoes," #FightCRC Medical Advisory Board Member and #ColorectalCancer survivor, Dustin Deming shares. uwhealth.org/news/battling-…

ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

#ComboMATCH Treatment Trial E5, led by Kristen Spencer of Perlmutter Cancer Center at NYU Langone Health and Dustin Deming of UW Health | Carbone Cancer Center, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine

#ComboMATCH Treatment Trial E5, led by <a href="/kspencer725/">Kristen Spencer</a> of <a href="/Perlmutter_CC/">Perlmutter Cancer Center at NYU Langone Health</a> and <a href="/DocDustyD/">Dustin Deming</a> of <a href="/UWCarbone/">UW Health | Carbone Cancer Center</a>, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine
PeerVoice (@peervoice) 's Twitter Profile Photo

Watch a new 3-part panel discussion led by Dr Marwan Fakih on options and opportunities to improve outcomes in patients with advanced #colorectalcancer. #PeerVoice #CRC #oncology #gastroenterology #AdvancedCRC Dr. Marwan G. Fakih @GIcancerdoc Dustin Deming peervoice.com/SCT?PromoCode=…

Watch a new 3-part panel discussion led by Dr Marwan Fakih on options and opportunities to improve outcomes in patients with advanced #colorectalcancer.
#PeerVoice #CRC #oncology #gastroenterology #AdvancedCRC 
<a href="/mgfakih/">Dr. Marwan G. Fakih</a> @GIcancerdoc <a href="/DocDustyD/">Dustin Deming</a> peervoice.com/SCT?PromoCode=…
The V Foundation for Cancer Research (@thevfoundation) 's Twitter Profile Photo

Yeah, what happens? Dustin Deming shares his story with colorectal cancer from both the patient and researcher perspective. Click the link to learn more. v.org/story/dr-demin…

Yeah, what happens? <a href="/DocDustyD/">Dustin Deming</a> shares his story with colorectal cancer from both the patient and researcher perspective. Click the link to learn more.
v.org/story/dr-demin…
UW Hematology-Oncology and Palliative Care (@uw_hemeoncpc) 's Twitter Profile Photo

Congratulations Dustin Deming on this outstanding achievement! Your tireless efforts to improve cancer treatments and engagement with @ecog to bring these approaches to patients throughout the nation are so important.

ASCO (@asco) 's Twitter Profile Photo

Management of CRC continues to evolve w/ the intro of new targeted therapies & strategies. An Ed. Session at #ASCO24 will review recent advances & ongoing trials aimed at further improving outcomes: brnw.ch/21wJVF0 #ASCODailyNews #GICSM #colorectalcancer #crcsm Dustin Deming

Management of CRC continues to evolve w/ the intro of new targeted therapies &amp; strategies. An Ed. Session at #ASCO24 will review recent advances &amp; ongoing trials aimed at further improving outcomes: brnw.ch/21wJVF0 #ASCODailyNews #GICSM #colorectalcancer #crcsm <a href="/DocDustyD/">Dustin Deming</a>
Katrina Pedersen, MD, MS (@drkatepedersen) 's Twitter Profile Photo

#ASCO24 CRC Orals: Completely agree with Kristen Ciombor- Don’t want to see any more neoadj dMMR IO trials reporting path responses (non validated as a relevant surrogate endpoint for colon relapse) with short median follow ups. Time to set the bar at DFS to report, IMO

#ASCO24 CRC Orals:

Completely agree with <a href="/KristenCiombor/">Kristen Ciombor</a>- 

Don’t want to see any more neoadj dMMR IO trials reporting path responses (non validated as a relevant surrogate endpoint for colon relapse) with short median follow ups. 

Time to set the bar at DFS to report, IMO
Jason Bergsbaken, PharmD, MBA, BCOP (@jbergrx) 's Twitter Profile Photo

Thankful and appreciative of the recognition at the 2024 ASCO Conference. Extra thankful for my supportive wife and family, to @MMably for the nomination and mentorship, and for the opportunity to collaborate with a wonderful team UW Health | Carbone Cancer Center and UW–Madison School of Pharmacy

Thankful and appreciative of the recognition at the 2024 ASCO Conference. Extra thankful for my supportive wife and family, to @MMably for the nomination and mentorship, and for the opportunity to collaborate with a wonderful team <a href="/UWCarbone/">UW Health | Carbone Cancer Center</a> and <a href="/UWMadPharmacy/">UW–Madison School of Pharmacy</a>